Human gene
SLC45A2 solute carrier family 45, member 2
2 disease groups in OMIA reach this gene, through the animal gene that Ensembl gives as its ortholog. The page shows the chain. It does not say whether an animal is a model of a human disease.
Animal diseases
By each group's best natural-model score, highest first. How the score works.
| OMIA group | Name | Species | Animal gene | Ortholog | The chain reached | Best score |
|---|---|---|---|---|---|---|
| 1821 | Coat colour, albinism, oculocutaneous type IV | dog | SLC45A2 | one to one | Target evidence |
69.6
|
| 1821 | Coat colour, albinism, oculocutaneous type IV | Japanese medaka | slc45a2 | one to one | Target evidence |
69.6
|
| 370 | Feather colour, SLC45A2-related | Japanese quail | SLC45A2 | one to one | Target evidence |
66.6
|
Target evidence
Each Open Targets association between this gene and a human disease that a disease group reached.
| Human disease | Mondo | Score | Evidence |
|---|---|---|---|
| oculocutaneous albinism type 4 | MONDO:0011683 | 0.85 | 244 |
Drugs
Each ChEMBL drug that acts on this gene.
No ChEMBL drug acts on this gene, among the genes with target evidence.